Skip to main content
CalculatePeptide
Long-acting GHRH analog with drug affinity complex

CJC-1295 with DAC Calculator

Dosage and reconstitution math for CJC-1295 with DAC. A long-acting GHRH analog with a drug affinity complex that covalently binds albumin to extend plasma half-life.

Reconstitution calculator

Pre-filled with common defaults for CJC-1295 with DAC. Adjust any field to match your own vial.

mg
mL
Draw to
units on the syringe
Equivalent volume: mL
Concentration
mcg / mL
Per syringe unit
mcg / unit
Show the math

Enter values above to see the step-by-step math.

Preview of the illustrated reconstitution guide
Free download

Free Illustrated Reconstitution Guide (PDF)

8-step visual walkthrough with photos and tips — from gathering supplies to drawing your dose. Educational only — not medical advice.

CJC-1295 with DAC reconstitution diagram CJC-1295 with DAC: 2 mg vial mixed with 2 mL bacteriostatic water yields 1 mg/mL. A 500 mcg dose draws to 50 units on a U-100 syringe. 1 Reconstitute 2 mg vial + 2 mL BAC water 2 Calculate concentration 1 mg/mL 2 mg ÷ 2 mL = 1 concentration 3 Convert dose to volume 500 mcg dose 500 mcg ÷ 1000 mcg/mL = 0.5 mL 4 Draw to mark 0 25 50 75 100 50 units U-100 2 mg vial · 2 mL water · 1 mg/mL · 500 mcg dose → 0.5 mL → 50 units on U-100

CJC-1295 with DAC dosage calculator

The CJC-1295 with DAC dosage calculator above converts a target dose into exact syringe units based on your vial size and how much bacteriostatic water you used to reconstitute it. CJC-1295 with DAC is commonly sold in 2 mg, 5 mg vials. The calculator supports both U-100 and U-40 insulin syringes and flags draws that are too large for the syringe barrel or too small to measure accurately. A long-acting GHRH analog with a drug affinity complex that covalently binds albumin to extend plasma half-life. Enter your target dose in the calculator above to see the exact number of units to draw.

CJC-1295 with DAC dosage chart

Sample doseConcentrationVolume to drawUnits on U-100
88 mcg1 mg/mL0.088 mL8.8
180 mcg1 mg/mL0.18 mL18
350 mcg1 mg/mL0.35 mL35
700 mcg1 mg/mL0.7 mL70
1400 mcg1 mg/mL1.4 mL140

CJC-1295 with DAC and GHRH peptides

CJC-1295 with DAC is a Long-acting GHRH analog with drug affinity complex. A long-acting GHRH analog with a drug affinity complex that covalently binds albumin to extend plasma half-life. Other peptides in the GHRH class include CJC-1295 (no DAC) , Sermorelin , and Tesamorelin .

CJC-1295 with DAC is a long-acting analog of growth hormone releasing hormone (GHRH) that incorporates a drug affinity complex (DAC) — a maleimide functional group that covalently binds circulating albumin. Published pharmacokinetic research reports that this albumin binding dramatically extends the molecule’s plasma half-life compared to native GHRH or the no-DAC variant. It has been studied for its effect on sustained, rather than pulsatile, growth hormone release. CJC-1295 with DAC is not approved by the FDA for human use. Research-grade material is sold as a laboratory reagent only.

See all GHRH peptides →

How to reconstitute CJC-1295 with DAC

Research vendors typically offer CJC-1295 with DAC in 2 mg or 5 mg lyophilized vials. Reconstitution with 2–3 mL of bacteriostatic water is commonly reported.

Reconstituting CJC-1295 with DAC is the same unit-conversion process used for any lyophilized peptide:

  1. Draw your chosen volume of bacteriostatic water into a syringe.
  2. Inject the bacteriostatic water slowly down the side of the CJC-1295 with DAC vial — do not shoot it directly onto the powder.
  3. Swirl gently until the powder fully dissolves. Do not shake.
  4. Store the reconstituted vial refrigerated.
  5. To dose, calculate your draw volume: divide your target dose by the concentration (vial mg ÷ water mL = mg/mL). The calculator above does this automatically.

For CJC-1295 with DAC specifically, 2 mg, 5 mg vials are common. A typical reconstitution adds 2 mL of bacteriostatic water, producing a concentration of 2.5 mg/mL for the 5 mg vial size.

CJC-1295 with DAC half-life and storage

Published pharmacokinetic studies report a plasma half-life of approximately 8 days for CJC-1295 with DAC, attributed to the covalent albumin binding.

Lyophilized CJC-1295 with DAC is typically stored refrigerated or frozen for long-term storage. Reconstituted solutions are commonly refrigerated and protected from light.

Common CJC-1295 with DAC dosing mistakes

Most CJC-1295 with DAC draw errors are unit errors, not arithmetic errors: confusing mg with mcg (1 mg = 1,000 mcg), or reading a U-40 syringe with U-100 math — the same printed mark holds 2.5× the volume. Two more worth avoiding: leaving the vial unlabeled, so the concentration and reconstitution date are lost, and under-diluting to the point where the draw is under about one unit and can no longer be read accurately.

Each of these is covered in full in the guides: reconstitution math from first principles, U-100 vs U-40 syringes, storage and shelf life, and how to reconstitute peptides.

CJC-1295 with DAC FAQ

What is CJC-1295 with DAC? +
CJC-1295 with DAC is a Long-acting GHRH analog with drug affinity complex. A long-acting GHRH analog with a drug affinity complex that covalently binds albumin to extend plasma half-life.
How do I calculate my CJC-1295 with DAC dose? +
Use the calculator above. Enter your vial size (2 mg, 5 mg are common for CJC-1295 with DAC), the amount of bacteriostatic water you added, and your target dose. The calculator returns the exact number of syringe units to draw.
What vial sizes does CJC-1295 with DAC come in? +
CJC-1295 with DAC is commonly available in 2 mg, 5 mg vials.
How long does CJC-1295 with DAC last? +
CJC-1295 with DAC's reported half-life is ~8 days.
How should I store CJC-1295 with DAC? +
Lyophilized CJC-1295 with DAC is typically stored refrigerated or frozen for long-term storage. Reconstituted solutions are commonly refrigerated and protected from light.

Published research on CJC-1295 with DAC

Indexed in PubMed. Listed for reference only — none of this is dosing guidance, and their presence here is not an endorsement of use.

General resources: PubMed, DailyMed, ClinicalTrials.gov.